Immune Response News and Research

RSS

"Escape mutations" could help SARS-CoV-2 evade immune attack

Researchers in the United States have identified mutations within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that can reduce antibody binding to the virus, potentially mediating its escape from immune attack.

18 Nov 2020

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

A team of researchers at the University of São Paulo in Brazil aimed to determine if vitamin D3 supplementation reduces the length of stay in hospitalized patients with severe COVID-19.

18 Nov 2020

COVID-19 during pregnancy can cause placental inflammation and impaired immunity

A new study conducted by a team of researchers at Johns Hopkins University, USA, has observed how pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show stunted antiviral immune responses.

18 Nov 2020

Severe COVID-19 complications linked to gut barrier breakdown

A new study claims that severe COVID-19 is caused by a positive feedback loop triggered by systemic inflammation and mediated by abnormal gut permeability. This finding could potentially help open up new avenues of treatment.

18 Nov 2020

SARS-CoV-2 causes a unique cytokine storm, study finds

A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.

18 Nov 2020

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a study being presented at the annual meeting of the Radiological Society of North America.

18 Nov 2020

Government-funded scientists laid the groundwork for billion-dollar vaccines

When he started researching a troublesome childhood infection nearly four decades ago, virologist Dr. Barney Graham, then at Vanderbilt University, had no inkling his federally funded work might be key to deliverance from a global pandemic.

18 Nov 2020

Diabetes and hypertension may increase the risk of COVID-19 brain complications

New data has revealed those with type 2 diabetes and hypertension are at an increased risk of neurological complications following infection with COVID-19.

18 Nov 2020

Children in Melbourne family developed COVID-19 immune response after exposure to virus

Children in a Melbourne family developed a COVID-19 immune response after chronic exposure to the SARS-CoV-2 virus from their parents, a new case report has found.

18 Nov 2020

New study may shed light on the adaptive immune response to COVID-19

New research funded by the National Cancer Institute (NCI) aims to boost understanding of how the immune system responds to COVID-19, from the start of infection to recovery.

18 Nov 2020

Certain regions in the retina are more affected by Alzheimer's disease, shows study

A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina - the lining found in the back of the eye - that are more affected by Alzheimer's disease than other areas.

18 Nov 2020

Study: e-cigarette users have increased susceptibility to flu, COVID-19

In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.

18 Nov 2020

Immunological memory can protect people against new infection after COVID-19 recovery

Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to persistent immunological memory and thus can protect against a new infection.

18 Nov 2020

Children's DTP vaccine may provide cross-immunity for COVID-19

He found that the viruses subject to pediatric vaccinations do not have cross-reactive epitopes for SARS-CoV-2, showing they cannot provide protection against COVID-19.

17 Nov 2020

UCLA researchers pinpoint how smoking causes more severe COVID-19 infection

UCLA researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes COVID-19, in the airways of the lungs.

17 Nov 2020

Males may have higher but more transient SARS-CoV-2 immunity than females post-infection

Adding another piece to the puzzle that is coronavirus disease 2019 (COVID-19) serology, a new study published on the preprint server medRxiv* in November 2020 suggests that males have stronger but more transient anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protective immunity than females.

17 Nov 2020

Targeting BCAP with new drugs could benefit people with inflammatory bowel disease

Managing the activity of the BCAP protein could help the body repair intestinal tissue from damage caused by inflammation, according to a new study led by experts at Cincinnati Children's.

17 Nov 2020

Study shows limited influence of BMI on shaping SARS-CoV-2 antibody responses

A new study by researchers at the Harvard Medical School and the Ragon Institute of MGH, MIT and Harvard showed that obesity is not tied to the increased risk of SARS-CoV-2 infection. However, the team demonstrated that obesity is associated with increased manifestations of symptoms in mild COVID-19 infections, suggesting that obesity impacts the pathophysiology of COVID-19.

16 Nov 2020

Significant SARS-CoV-2 vaccine hesitancy in the U.S.

A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).

16 Nov 2020

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Researchers in France have conducted a study showing that people who are asymptomatic following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – elicit a polyfunctional antibody response to the virus.

16 Nov 2020

Immune Response News and Research

"Escape mutations" could help SARS-CoV-2 evade immune attack

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

COVID-19 during pregnancy can cause placental inflammation and impaired immunity

Severe COVID-19 complications linked to gut barrier breakdown

SARS-CoV-2 causes a unique cytokine storm, study finds

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Government-funded scientists laid the groundwork for billion-dollar vaccines

Diabetes and hypertension may increase the risk of COVID-19 brain complications

Children in Melbourne family developed COVID-19 immune response after exposure to virus

New study may shed light on the adaptive immune response to COVID-19

Certain regions in the retina are more affected by Alzheimer's disease, shows study

Study: e-cigarette users have increased susceptibility to flu, COVID-19

Immunological memory can protect people against new infection after COVID-19 recovery

Children's DTP vaccine may provide cross-immunity for COVID-19

UCLA researchers pinpoint how smoking causes more severe COVID-19 infection

Males may have higher but more transient SARS-CoV-2 immunity than females post-infection

Targeting BCAP with new drugs could benefit people with inflammatory bowel disease

Study shows limited influence of BMI on shaping SARS-CoV-2 antibody responses

Significant SARS-CoV-2 vaccine hesitancy in the U.S.

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News